Trintellix and Kesimpta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Trintellix (vortioxetine hydrobromide) and Kesimpta (ofatumumab). Common drug interactions include headache among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Trintellix and Kesimpta. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Trintellix?

Trintellix has active ingredients of vortioxetine hydrobromide. It is often used in depression. eHealthMe is studying from 13,067 Trintellix users. Check the latest studies of Trintellix.

What is Kesimpta?

Kesimpta has active ingredients of ofatumumab. eHealthMe is studying from 36,592 Kesimpta users. Check the latest studies of Kesimpta.



On Jul, 18, 2026

25 people who take Trintellix and Kesimpta together, and have interactions are studied.

Trintellix and Kesimpta drug interactions.

What are the common drug interactions of Trintellix and Kesimpta, by gender? *:

female:

  1. Headache (pain in head)
  2. Hyperhidrosis (abnormally increased sweating)
  3. Feeling hot
  4. Pruritus (severe itching of the skin)
  5. Nausea (feeling of having an urge to vomit)
  6. Chills (felling of cold)
  7. Cellulitis (infection under the skin)
  8. Pain
  9. Rash
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

male:

  1. Dizziness
  2. Abdominal pain
  3. Constipation
  4. Diarrhoea
  5. Dysuria (painful or difficult urination)
  6. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  7. Fatigue (feeling of tiredness)
  8. Feeling cold
  9. Gout (uric acid crystals building up in the body)
  10. Headache (pain in head)

What are the common drug interactions of Trintellix and Kesimpta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Dizziness
  2. Abdominal pain
  3. Abdominal pain lower
  4. Abdominal pain upper
  5. Anxiety
  6. Arthralgia (joint pain)
  7. Asthenia (weakness)
  8. Back pain
  9. Blood alkaline phosphatase increased
  10. Central nervous system lesion (an abnormality in tissue of brain or spinal cord)

40-49:

  1. Chills (felling of cold)
  2. Pyrexia (fever)
  3. Swelling face
  4. Vomiting
  5. Cellulitis (infection under the skin)
  6. Feeling hot
  7. Hyperhidrosis (abnormally increased sweating)
  8. Pruritus (severe itching of the skin)
  9. Depressed mood
  10. Infection

50-59:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Clumsiness (a lack of coordination or elegance)
  3. Headache (pain in head)
  4. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)

60+:

n/a

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 13 people, 52.00%

* Approximation only. Some reports may have incomplete information.

Do you take Trintellix and Kesimpta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Trintellix and Kesimpta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Trintellix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Kesimpta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Trintellix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kesimpta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on vortioxetine hydrobromide and ofatumumab (the active ingredients of Trintellix and Kesimpta, respectively), and Trintellix and Kesimpta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: